deltatrials
Recruiting PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT04903873

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

An Open-Label, Phase 1/2 Study to Evaluate Safety, Efficacy, and Pharmacokinetics of EU101, an Agonistic Anti-CD137 (4-1BB) Monoclonal Antibody in Patients With Advanced Solid Tumors

Sponsor: Eutilex

Conditions Non-Small Cell Lung Cancer Prostate Cancer Renal Cell Cancer Metastatic Renal Cell Carcinoma Solid Tumor
Interventions EU101
Updated 9 times since 2021 Last updated: Mar 13, 2024 Started: May 31, 2021 Primary completion: Sep 30, 2025 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Non-Small Cell Lung Cancer and Prostate Cancer, this trial is actively recruiting participants. The trial is conducted by Eutilex and has accumulated 9 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Sep 2022 · 9 months · monthly snapshotRecruiting~Sep 2022 – ~Apr 2023 · 7 months · monthly snapshotRecruiting~Apr 2023 – ~Apr 2024 · 12 months · monthly snapshotRecruiting~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotRecruiting~Sep 2025 – present · 10 months · monthly snapshotRecruiting

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Recruiting PHASE1/PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Recruiting PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  4. Apr 2024 — Jul 2024 [monthly]

    Recruiting PHASE1_PHASE2

  5. Apr 2023 — Apr 2024 [monthly]

    Recruiting PHASE1_PHASE2

▶ Show 4 earlier versions

  1. Sep 2022 — Apr 2023 [monthly]

    Recruiting PHASE1_PHASE2

  2. Dec 2021 — Sep 2022 [monthly]

    Recruiting PHASE1_PHASE2

  3. Sep 2021 — Dec 2021 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Not Yet Recruiting → Recruiting

  4. Jun 2021 — Sep 2021 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

    First recorded

May 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eutilex
Data source: Eutilex

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations